在稳定的慢性阻塞性肺病患者中开发和验证名录模型来预测死亡率:RealDTC队列中的前性观察研究
Wei Cheng1,2, Aiyuan Zhou3, Qing Song1,2
1Department of Pulmonary and Critical Care Medicine, Second Xiangya Hospital; Research Unit of Respiratory Disease; Diagnosis and Treatment Centre of Respiratory Disease, Central South University, Changsha, Hunan, China.
Journal of global health
|February 22, 2024
概括
一种新的名ogram模型,ABEODS,准确地预测稳定慢性阻塞性肺病 (COPD) 患者的死亡率. 该模型的性能优于以前的工具,为个性化护理提供了改进的预后评估.
科学领域:
- 肺部医学 肺部医学
- 医学统计 医学统计
- 预测建模预测建模
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球主要的死亡原因.
- 现有的稳定的COPD死亡率预测模型缺乏.
- 需要准确的预后工具来进行个性化患者评估.
研究的目的:
- 开发和验证一种名谱模型,用于预测稳定的COPD患者的死亡风险.
- 为COPD管理提供个性化的预后评估工具.
主要方法:
- 对2499名COPD门诊患者进行了前性观察性研究.
- 患者被分为培训 (70%) 和验证 (30%) 队列.
- 拉索回归用于变量选择,并使用AUC和校准曲线评估预后性能.
主要成果:
- 开发了ABEODS nomogram,包括年龄,BMI,教育,气流阻塞,呼吸困难和恶化.
- 该模型在培训和验证队列中显示出强有力的三年死亡率预测,AUC分别为0.84和0.80.
- 与BODEx,更新的ADO和DOSE相比,ABEODS模型显示出更高的性能.
结论:
- 一个经验证的预后名录 (ABEODS) 准确地预测了稳定的COPD患者的死亡率.
- 在中国的COPD患者中,ABEODS模型提供了比现有模型更好的预测准确度.
- 这种工具有助于个性化预后评估,并可能增强COPD管理策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


